Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
- Clearview Cancer Center
Huntsville, Alabama, United States
- Radiology Associates of Sacramento/sutter Cancer Center
Sacramento, California, United States
- Emory University
Atlanta, Georgia, United States
- Northside Hospital/ga Cancer Specialists
Atlanta, Georgia, United States
- University of Louisville
Louisville, Kentucky, United States
- Hematology and Oncology Assoc. at Bridgeport
Tupelo, Mississippi, United States
- Washington University/alvin J. Siteman Cancer Center
St Louis, Missouri, United States
- Providence Portland Medical Center/providence Cancer Center
Portland, Oregon, United States
- Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Dec 2012
- Completion
- 31 Dec 2012
- Last update posted
- 11 Jun 2021
- Registered enrollment
- 70
- Registry id
- NCT00932438
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.